Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Cooper

Showing results (51-60 of 144) with videos related to

Pageof 15
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2017
Synergistic effects of treating the spinal cord and brain in CLN1 diseaseCharles Shyng, Hemanth R Nelvagal, Joshua T Dearborn, et al.
Human Molecular Genetics|May 25, 2002
An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten diseaseSubrata Chattopadhyay, Masumi Ito, Jonathan D Cooper, et al.
Neuropharmacology|October 26, 2010
Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten diseaseAttila D Kovács, Angelika Saje, Andrew Wong, et al.
Biological Psychiatry|January 17, 2012
Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmationAnthony C Vernon, Sridhar Natesan, William R Crum, et al.
Journal of Inherited Metabolic Disease|February 8, 2012
Combination small molecule PPT1 mimetic and CNS-directed gene therapy as a treatment for infantile neuronal ceroid lipofuscinosisMarie S Roberts, Shannon L Macauley, Andrew M Wong, et al.
The Journal of Biological Chemistry|October 22, 2005
High resolution 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten diseaseMichael R Pears, Jonathan D Cooper, Hannah M Mitchison, et al.
Psychopharmacology|July 6, 2021
Brain volume in chronic ketamine users - relationship to sub-threshold psychotic symptoms and relevance to schizophreniaRobert A Chesters, Fiona Pepper, Celia Morgan, et al.
The Journal of Clinical Investigation|August 28, 2025
Reduced heparan sulfate levels in cerebrospinal fluid reflect brain neuron correction in Sanfilippo B miceSteven Q Le, Alexander Sorensen, Soila Sukupolvi, et al.
Developmental Biology|February 15, 2005
FGFR3 regulates brain size by controlling progenitor cell proliferation and apoptosis during embryonic developmentSuzanne L Inglis-Broadgate, Rachel E Thomson, Francesca Pellicano, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 18, 2015
Longitudinal in vivo maturational changes of metabolites in the prefrontal cortex of rats exposed to polyinosinic-polycytidylic acid in uteroAnthony C Vernon, Po-Wah So, David J Lythgoe, et al.
Pageof 15

Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2017
Synergistic effects of treating the spinal cord and brain in CLN1 diseaseCharles Shyng, Hemanth R Nelvagal, Joshua T Dearborn, et al.
Human Molecular Genetics|May 25, 2002
An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten diseaseSubrata Chattopadhyay, Masumi Ito, Jonathan D Cooper, et al.
Neuropharmacology|October 26, 2010
Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten diseaseAttila D Kovács, Angelika Saje, Andrew Wong, et al.
Biological Psychiatry|January 17, 2012
Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmationAnthony C Vernon, Sridhar Natesan, William R Crum, et al.
Journal of Inherited Metabolic Disease|February 8, 2012
Combination small molecule PPT1 mimetic and CNS-directed gene therapy as a treatment for infantile neuronal ceroid lipofuscinosisMarie S Roberts, Shannon L Macauley, Andrew M Wong, et al.
The Journal of Biological Chemistry|October 22, 2005
High resolution 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten diseaseMichael R Pears, Jonathan D Cooper, Hannah M Mitchison, et al.
Psychopharmacology|July 6, 2021
Brain volume in chronic ketamine users - relationship to sub-threshold psychotic symptoms and relevance to schizophreniaRobert A Chesters, Fiona Pepper, Celia Morgan, et al.
The Journal of Clinical Investigation|August 28, 2025
Reduced heparan sulfate levels in cerebrospinal fluid reflect brain neuron correction in Sanfilippo B miceSteven Q Le, Alexander Sorensen, Soila Sukupolvi, et al.
Developmental Biology|February 15, 2005
FGFR3 regulates brain size by controlling progenitor cell proliferation and apoptosis during embryonic developmentSuzanne L Inglis-Broadgate, Rachel E Thomson, Francesca Pellicano, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 18, 2015
Longitudinal in vivo maturational changes of metabolites in the prefrontal cortex of rats exposed to polyinosinic-polycytidylic acid in uteroAnthony C Vernon, Po-Wah So, David J Lythgoe, et al.
Pageof 15